Search Results

There are 4608 results for: content related to: Attenuation of the disruptive effects of (+/-)3,4-methylenedioxymethamphetamine and cocaine on delayed matching-to-sample performance with D1 versus D2 antagonists

  1. You have free access to this content
    The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives

    British Journal of Pharmacology

    Volume 160, Issue 5, July 2010, Pages: 1029–1044, JR Docherty and AR Green

    Version of Record online : 3 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00722.x

  2. REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade

    Addiction Biology

    Volume 12, Issue 3-4, September 2007, Pages: 227–462, Thomas M. Tzschentke

    Version of Record online : 30 JUL 2007, DOI: 10.1111/j.1369-1600.2007.00070.x

  3. You have free access to this content
    The preclinical pharmacology of mephedrone; not just MDMA by another name

    British Journal of Pharmacology

    Volume 171, Issue 9, May 2014, Pages: 2251–2268, A R Green, M V King, S E Shortall and K C F Fone

    Version of Record online : 11 APR 2014, DOI: 10.1111/bph.12628

  4. You have free access to this content
    Studies on the effect of MDMA (‘ecstasy’) on the body temperature of rats housed at different ambient room temperatures

    British Journal of Pharmacology

    Volume 146, Issue 2, September 2005, Pages: 306–312, A Richard Green, Esther O'Shea, Kathryn S Saadat, J Martin Elliott and M Isabel Colado

    Version of Record online : 30 JAN 2009, DOI: 10.1038/sj.bjp.0706318

  5. You have free access to this content
    Mechanisms mediating the ability of caffeine to influence MDMA (‘Ecstasy’)-induced hyperthermia in rats

    British Journal of Pharmacology

    Volume 160, Issue 4, June 2010, Pages: 860–877, N Vanattou-Saïfoudine, R McNamara and A Harkin

    Version of Record online : 24 MAY 2010, DOI: 10.1111/j.1476-5381.2010.00660.x

  6. MDMA and Other “Club Drugs”

    Standard Article

    Handbook of Contemporary Neuropharmacology

    M. Isabel Colado, Esther O'Shea and A. Richard Green

    Published Online : 2 MAR 2007, DOI: 10.1002/9780470101001.hcn039

  7. Adolescent pre-exposure to ethanol and 3,4-methylenedioxymethylamphetamine (MDMA) increases conditioned rewarding effects of MDMA and drug-induced reinstatement

    Addiction Biology

    Volume 17, Issue 3, May 2012, Pages: 588–600, Bruno Ribeiro Do Couto, Manuel Daza-Losada, Marta Rodríguez-Arias, Roser Nadal, Consuelo Guerri, Teresa Summavielle, Jose Miñarro and Maria A. Aguilar

    Version of Record online : 13 OCT 2011, DOI: 10.1111/j.1369-1600.2011.00382.x

  8. The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 2, August 2011, Pages: 246–255, CM Hysek, LD Simmler, M Ineichen, E Grouzmann, MC Hoener, R Brenneisen, J Huwyler and ME Liechti

    Version of Record online : 15 JUN 2011, DOI: 10.1038/clpt.2011.78

  9. You have free access to this content
    MDMA ‘ecstasy’ increases cerebral cortical perfusion determined by bolus-tracking arterial spin labelling (btASL) MRI

    British Journal of Pharmacology

    Volume 169, Issue 5, July 2013, Pages: 974–987, J Rouine, O L Gobbo, M Campbell, V Gigliucci, I Ogden, K McHugh Smith, P Duffy, B Behan, D Byrne, M E Kelly, C W Blau, C M Kerskens and A Harkin

    Version of Record online : 12 JUN 2013, DOI: 10.1111/bph.12178

  10. You have free access to this content
    The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) to rats

    British Journal of Pharmacology

    Volume 135, Issue 1, January 2002, Pages: 170–180, Annis O Mechan, Blanca Esteban, Esther O'Shea, J Martin Elliott, M Isabel Colado and A Richard Green

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0704442

  11. You have free access to this content
    A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) on dopamine neurones in mouse brain

    British Journal of Pharmacology

    Volume 134, Issue 8, December 2001, Pages: 1711–1723, M Isabel Colado, Jorge Camarero, Annis O Mechan, Veronica Sanchez, Blanca Esteban, J Martin Elliott and A Richard Green

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0704435

  12. You have free access to this content
    Methylenedioxymethamphetamine inhibits mitochondrial complex I activity in mice: a possible mechanism underlying neurotoxicity

    British Journal of Pharmacology

    Volume 160, Issue 2, May 2010, Pages: 233–245, Elena Puerta, Isabel Hervias, Beatriz Goñi-Allo, Steven F Zhang, Joaquín Jordán, Anatoly A Starkov and Norberto Aguirre

    Version of Record online : 23 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00663.x

  13. You have free access to this content
    Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility

    Journal of Neurochemistry

    Volume 124, Issue 1, January 2013, Pages: 69–78, Lucia Frau, Nicola Simola, Antonio Plumitallo and Micaela Morelli

    Version of Record online : 15 NOV 2012, DOI: 10.1111/jnc.12060

  14. You have free access to this content
    Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): a stressor on the immune system

    Immunology

    Volume 111, Issue 4, March 2004, Pages: 357–367, Thomas J. Connor

    Version of Record online : 30 MAR 2004, DOI: 10.1111/j.0019-2805.2004.01847.x

  15. You have free access to this content
    Methylenedioxymethamphetamine (‘Ecstasy’)-induced immunosuppression: a cause for concern?

    British Journal of Pharmacology

    Volume 161, Issue 1, September 2010, Pages: 17–32, Noreen T Boyle and Thomas J Connor

    Version of Record online : 25 MAY 2010, DOI: 10.1111/j.1476-5381.2010.00899.x

  16. Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases

    Human Psychopharmacology: Clinical and Experimental

    Volume 27, Issue 4, July 2012, Pages: 352–363, Cecilie L. Licht, Maria Christoffersen, Mads Okholm, Lærke Damgaard, Anders Fink-Jensen, Gitte M. Knudsen and David Erritzoe

    Version of Record online : 14 JUN 2012, DOI: 10.1002/hup.2234

  17. Examining the role of oxytocin in the interoceptive effects of 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) using a drug discrimination paradigm in the rat

    Addiction Biology

    Volume 16, Issue 2, April 2011, Pages: 202–214, Jillian H. Broadbear, Brendan Tunstall and Katherine Beringer

    Version of Record online : 11 NOV 2010, DOI: 10.1111/j.1369-1600.2010.00267.x

  18. Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat

    Journal of Pharmaceutical Sciences

    Volume 97, Issue 4, April 2008, Pages: 1593–1605, Vijay V. Upreti and Natalie D. Eddington

    Version of Record online : 27 AUG 2007, DOI: 10.1002/jps.21045

  19. Recovery and aging of serotonergic fibers after single and intermittent MDMA treatment in dark agouti rat

    Journal of Comparative Neurology

    Volume 519, Issue 12, 15 August 2011, Pages: 2353–2378, Csaba Ádori, Rómeó D. Andó, Mária Szekeres, Lise Gutknecht, Gábor G. Kovács, László Hunyady, Klaus-Peter Lesch and György Bagdy

    Version of Record online : 27 JUN 2011, DOI: 10.1002/cne.22631

  20. (±)3,4-methylenedioxymethamphetamine (“ecstasy”) treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain

    Journal of Comparative Neurology

    Volume 520, Issue 11, 1 August 2012, Pages: 2459–2474, Ann M. Hemmerle, Jonathan W. Dickerson, Nicole R. Herring, Tori L. Schaefer, Charles V. Vorhees, Michael T. Williams and Kim B. Seroogy

    Version of Record online : 14 MAY 2012, DOI: 10.1002/cne.23048